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1. The cytosolic aspartate aminotransferase was purified from human liver. 2. The isoenzyme contains four cysteine
residues, only one of which reacts with 5,5'-dithiobis-(2-nitrobenzoic acid) in the absence of denaturing agents. 3. The
amino acid sequence of the isoenzyme is reported, as determined from peptides produced by digestion with trypsin and
with CNBr, and from sub-digestion of some of these peptides with Staphylococcus aureus V8 proteinase. 4. The isoenzyme
shares 48 % identity ofamino acid sequence with the mitochondrial form from human heart. 5. Comparisons of the amino
acid sequences of all known mammalian cytosolic aspartate aminotransferases and of the same set of mitochondrial
isoenzymes are reported. The results indicate that the cytosolic isoenzymes have evolved at about 1.3 times the rate of the
mitochondrial forms. 6. The time elapsed since the cytosolic and mitochondrial isoenzymes diverged from a common
ancestral protein is estimated to be 860 x 106 years. 7. Experimental details and confirmatory data for the results presented
here are given in a supplementary paper that has been deposited as a Supplementary Publication SUP 50158 (25 pages)
at the British Library Document Supply Centre, Boston Spa, Wetherby, West Yorkshire LS23 7BQ, U.K., from whom
copies can be obtained on the terms indicated in Biochem. J. (1990) 265, 5.
INTRODUCTION
The cytosolic and mitochondrial aspartate aminotransferases
(EC 2.6.1.1) are coded for by different, but structurally related,
genes. This was initially shown by amino acid sequence analysis
of the two isoenzymes from pig heart [1-3]. Subsequently a
considerable amount of work has been done on structure
determination of aspartate aminotransferases from various
sources with the use of both classical protein sequencing methods
and, more recently, cDNA sequencing [4-12].
The results of this work are important in that they provide
insights into the evolutionary processes that have given rise to
the aspartate aminotransferases.
An interesting, but open, question in this context has been
whether the two isoenzymes have evolved at equal rates, or
whether the specific requirement for import of the mitochondrial
isoenzyme from its site of synthesis in the cell cytosol into the
organelles has imposed extra constraints on its structure and
hence on its rate of evolution. Early indirect evidence based on
immunochemical comparisons suggested that mammalian cyto-
solic aspartate aminotransferases have evolved at about twice the
rate of their mitochondrial counterparts [13], whereas com-
parisons oflimited sequence data indicated little, if any, difference
in rate [14]. More recently [9] we presented a quantitative
comparison of the sequence differences for all aspartate amino-
transferases whose structures had been determined. These results
suggested a nearly equal rate of evolution of the mammalian
isoenzymes, but were not conclusive since the sequences of only
two mammalian cytosolic aspartate aminotransferases were
known at that time. Consequently, we decided to extend the list
of known sequences by determining that of the cytosolic iso-
enzyme from human liver; the results are reported in the present
paper. In the meanwhile, amino acid sequences of the cytosolic
aspartate aminotransferases from mouse [10] and rat [11], based
on cDNA sequences, have been published, allowing for a more
refined comparison of sequence differences; these comparisons
are also presented here.
MATERIALS AND METHODS
Materials
CNBr and fluoren-9-ylmethyloxycarbonyl chloride were from
Aldrich Chemical Co., dansyl-amino acids were from Mann
Research Laboratories, phenyl isothiocyanate and amino acid
standards were from Pierce Chemical Co., h.p.l.c.-grade solvents,
pyridine and trifluoroacetic acid were from Rathburn Chemical
Co., and all proteolytic enzymes, amino acid phenylthio-
hydantoin derivatives and most other materials were from Sigma
Chemical Co. Reagents used for gas-phase sequencing were
supplied by Applied Biosystems.
Enzyme purification
Human liver was obtained at autopsy and stored at -20 °C
until use. Aspartate aminotransferase was isolated by modifi-
cation of the method previously reported [15], with final
purification on Cibacron Blue-Sepharose CL-6B [16]. Details are
given in Supplementary Publication SUP 50158.
Structure analysis
Experimental details of the following procedures are described
in Supplementary Publication SUP 50158: carboxymethylation
of the enzyme; cleavage of carboxymethylated protein with
trypsin and with CNBr; peptide fractionation by gel filtration;
peptide purification by reverse-phase h.p.l.c.; sub-digestion of
purified peptides with Staphylococcus aureus V8 proteinase;
N-terminal analysis by dansylation; C-terminal analysis by di-
gestion with carboxypeptidase Y; amino acid analysis; sequence
analysis by the dansyl-Edman method and by automated gas-
phase methods.
Thiol group analysis
This was done by the method of Ellman [17].
Native enzyme (2 mg) was incubated at 25 °C for 2 h in
0.1 M-sodium phosphate buffer, pH 8.0, containing 2.66 mm-
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dithiothreitol and 1.3 mM-EDTA. Reagents were removed by gel
filtration through a Sephadex G-25 (superfine grade) column
(1.5 cm x 11 cm) equilibrated in 0.1 M-sodium phosphate buffer,
pH 8.0. To the fraction containing enzyme was added 0.4 mg of
5,5'-dithiobis-(2-nitrobenzoic acid), and the absorbance change
was measured at 412 nm. Then 300 ,1 of 10% (w/v) SDS was
added, and the further absorbance change was measured.
The protein concentration was measured by the method of
Lowry et al. [18], with BSA as standard.
Sequence comparisons
Alignment of amino acid sequences was done by using the
computer program of Lipman & Pearson [19]. Quantitative
comparisons of sequences were made in terms of the parameter
K. as defined by Kimura [20], which provides an estimate of the
average number of substitutions per site between two sequences.
RESULTS AND DISCUSSION
Purification of cytosolic aspartate aminotransferase from human
liver
Results of a typical purification are given in Table 1, starting
from 550 g of liver. The yield is based on activity after the heat-
treatment step, since the initial homogenate also contained the
mitochondrial isoenzyme, which is heat-labile [15]. In fact, not all
of the mitochondrial isoenzyme was destroyed by heat treatment.
When the CM-cellulose column was washed with 1.0 M-NaCl
after elution of cytosolic isoenzyme with 0.1 M-NaCI, then a
further 2000 units of activity were eluted; this activity was due to
the mitochondrial isoenzyme and accounts for the relatively poor
yield from this step.
An overall yield of 15 mg of protein was obtained. The
product was pure as judged by SDS/PAGE and by cellulose
acetate electrophoresis at pH 8.6 (results not shown). In addition,
the enzyme was subjected to N-terminal analysis by the dansyl
method; a single N-terminal residue, alanine, was observed.
Hence the purification method described yielded a cytosolic
aspartate aminotransferase in sufficient quantity and state of
purity for sequence analysis.
Amino acid analysis
The amino acid composition of oxidized enzyme was de-
termined after hydrolysis for 24, 48 and 72 h. The numbers of
residues found per subunit (Mr 46000) are given in Table 2. For
most residues the values are the means of three determinations.
In the cases of serine and threonine the values are those
extrapolated back to zero time of hydrolysis. The value for
methionine was determined on an unoxidized protein sample.
Tryptophan was not determined.
Table 1. Purification of cytosolic aspartate aminotransferases from human
liver
Specific
Activity Protein activity Yield
Step (units) (mg) (units/mg) (%)
Homogenate
Heat step
(NH4)2SO4 fractionation
CM-cellulose CM23
DEAE-cellulose DE52
CM-Sephadex C-50
Blue Sepharose CL-6B
22450
10743
9684
5850
4433
3831
2774
n.d.
n.d.
n.d.
1955
526
75
15
n.d.
n.d.
n.d.
3.0
8.4
51.1
185.0
(100)
90
55
41
36
26
The values are generally in acceptable agreement with those
calculated from the amino acid sequence (see below).
Thiol group analysis
The native enzyme was reacted with 5,5'-dithiobis-(2-nitro-
benzoic acid) in the presence and in the absence of SDS. In the
absence of SDS, somewhat less than one residue of cysteine
could be titrated. This is similar to the behaviour with the bovine
enzyme [21], but differs from that of the enzymes from pig and
horse [22], where two residues react rapidly with the reagent. The
rapidly reacting residues in the pig enzyme are Cys-45 and Cys-
82 [23], both of which are present in the enzyme from human
liver (see below). The reason why one of these residues is
unreactive in the human isoenzyme is not known.
In the presence of SDS 3.3 residues of cysteine could be
titrated, whereas the number of cysteine residues determined
from sequence analysis is 4. The cytosolic aspartate amino-
transferases from pig and horse contain five cysteine residues,
one ofwhich, Cys-390, shows the interesting property ofincreased
reactivity in the presence of substrates [22]. It is notable that
position 390 is occupied by a serine residue in the isoenzyme
from human liver (see below), emphasizing that Cys-390 in other
cytosolic aspartate aminotransferases plays no special part in
catalysis.
Peptides from digestion with trypsin
Carboxymethylated protein (35 mg) was digested with trypsin,
and the peptides produced were partially purified by gel filtration
through Sephadex G-25 (superfine grade). Fractions were pooled
on the basis of N-terminal analysis and analytical t.l.c. on
cellulose plates with the solvent system butan-l-ol/acetic acid/
Table 2. Amino acid composition of human liver cytosolic aspartate
aminotransferase
The analyses were performed on oxidized samples of protein except
for methionine, where an unoxidized sample was used. Values are
the means (range + 10 % or better) of the three determinations after
hydrolysis for 24, 48 and 72 h except for serine and threonine, for
which values were obtained by extrapolation back to zero time of
hydrolysis. Tryptophan was not determined (N.B.).
Amino acid composition
(mol/mol of protein)
Amino acid
Amino acid analysis Sequence
Cysteine
Arginine
Serine
Aspartic acid/asparagine
Glutamic acid/glutamine
Threonine
Glycine
Alanine
Proline
Methionine
Valine
Phenylalanine
Isoleucine
Leucine
Histidine
Lysine
Tyrosine
Tryptophan
Total
5
21
27
37
44
23
32
35
21
4
28
20
18
39
9
20
11
N.D.
4
24
27
44
41
21
28
34
24
5
31
23
19
37
8
21
12
9
412
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Human cytosolic aspartate aminotransferase
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- ~~~--------------CN2--------------> -C3
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SFTGLNPKQVEYLVNEKHIYLLPSGRINVSGLTKNLDYVATSIHEAVTKIQ
------->--+T35--)+T36---<-T37--;+ T38 3 e*
Fig. 1. Amino acid sequence of cytosolic aspartate aminotransferase from human liver
Underlinings show the peptides on which the sequence was based; dashed underlinings show peptides or parts of peptides for which only amino
acid compositions were obtained. Overlinings show residues identified by digestion of peptides with carboxypeptidase Y. T, CN, SA and TH signify
peptides produced by digestion with trypsin, CNBr, S. aureus V8 proteinase and thermolysin respectively. TC I and TC2 signify peptides produced
by chymotryptic-like cleavage in the digestion with trypsin. In numbering the sequence the first digit is placed over the residue specified by that
number.
water/pyridine (15:3:12:10, by vol.) with detection by fluor-
escamine. Thirteen pooled fractions were taken.
Peptides in the pooled fractions were further purified by
h.p.l.c. on C18 reverse-phase columns. A total of 34 peptides were
isolated, two of which arose from chymotryptic-like cleavage (at
leucine and phenylalanine). Purity of peptides was assessed by
N-terminal analysis.
All peptides were subjected to amino acid analysis, and the
majority of them were sequenced, either partially or completely,
by the dansyl-Edman method (experimental data are given in
Supplementary Publication SUP 50158). The positions of the
peptides isolated are shown in Fig. 1, with the peptides numbered
in order from the N-terminus. Some peptides expected on the
basis of the amino acid sequence (e.g. T-8 and T-9) were not
isolated.
Some of the peptides were subjected to digestion with carboxy-
peptidase Y, and the amino acids liberated were identified as a
function of time of hydrolysis. The results obtained are sum-
marized in Fig. 1.
Peptides from digestion with CNBr
Carboxymethylated protein (20 mg) was digested with CNBr,
and the products were partially purified by gel filtration through
Sephadex G-50 (fine grade). Two peptides (CN-3 and CN-6)
were obtained in a pure state in pools P4 and P3 respectively
from gel filtration. Peptides CN-1 and CN-2 were co-eluted in
pool P1, and were separated by gel filtration through Sephadex
G-75 (superfine grade). Peptide CN-5 was purified from pool P5
by h.p.l.c. along with a peptide (Ala-327-Met-359) resulting
from failure to cleave at Met-333.
CNBr-cleavage peptides were subjected to amino acid analysis
and to partial or complete sequence analysis by means of the gas-
phase method. Repetitive yields during sequencing were in the
range 91-96 %. The sequence data obtained are summarized in
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20 40 60
APPSVFAEVPQAQPVLVFKLTADFREDPDPRKVNLGVGAYRTDDCHPWVLPVVKKVEQKI
I Q R R
*TSP I v Q R
F Q P I D SQ R
Q P D ESQ R
*AA I A R P A G S EGQ R L
80 100 12
ANDNSLNHEYLPILGLAEFRSCASRLALGDDSPALKEKRVGGVQSLGGTGALRIGADFLA
S T Q E
NS Q E S
H QV N RN G
P AN
V N IR N
I IAQ S G
140
D
D
N TA
I
160
G
180
G TT T S
G G H T
G
S MD
P C
T A L S M K
200 220 240
PEFSIVVLHACAHNPIGIDPTPEQWKQIASVMKRRFLFPFFDSAYQGFASGLERDAWAI
F T K
T
T E E A
T A Q
T DE A C
D
D K
D K
K
V
V
260 280 300
Human RYFVSEGFEFFCAQSFSKNFGLYNERVGNLTVVGKEPESILQV[SQMEKIVRITWSNPPA
Pig L A D R Q V
Horse L A D R Q
Rat L HD V R
Mouse L SD V R
Chicken L S DEDNVQR T S
320 340 360
Human QGARIVASTLSNPELFEGEWNVKTMADRILTMERSELRARLEALKTPGTWHITDQIGMF
Pig R D H S
Horse F D G K S E
Rat T K K S E
Mouse A D K K S E
Chicken T TS Q A KD V L S SG
380 400
Human SFTGLNPKQVEYLVNEHHIYLLPSGRINVSGLTKNELDYVATSIHEAVTKIQ
Pig I MC
Horse MC F
Rat M MC N F
Mouse MC
Chicken MIK MA MC K
Fig. 2. Comparison of the amino acid sequences of cytosolic aspartate aminotransferases
For isoenzymes other than human, only residues that differ from those in the human form are shown. The symbol - at position 120 in the
isoenzyme from chicken indicates a deletion. The symbol * at the N-terminus of the isoenzymes from horse and chicken indicates acetylated
residues. The amino acid sequences of the isoenzymes from pig [3], horse [9] and chicken [4] were determined by direct protein sequencing; those
of the isoenzymes from rat [11] and mouse [10] were obtained by cDNA sequencing.
Fig. 1, and detailed results are given in Supplementary Pub-
lication SUP 50158.
Sub-digestion of peptides
Peptides T-18 and T-28 were sub-digested with S. aureus V8
proteinase, as also were CNBr-cleavage peptides CN- 1 and
CN-6. Peptide T-34 was sub-digested with thermolysin. Product
peptides were purified by h.p.l.c. Peptides were subjected to
amino acid analysis and to sequence analysis by either the gas-
phase method or the dansyl-Edman method (see Supplementary
Publication SUP 50158).
Peptide SA-21A was subjected to digestion with carboxy-
peptidase Y. Lysine was identified as the C-terminal residue. This
was important, since evidence for this residue (Lys-324) was
otherwise indirect.
The sequence information obtained from sub-digests is sum-
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F
F
F
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Human cytosolic aspartate aminotransferase
20 40 60
APPSVFAEVEiQPVLVFLTADFREDPV GRIPVlPRKXEK
:~~*: : :e * : :- : * *: ::::: : *: .::: : .: : *:
SSWWHVEGPPDPIGVEAFKRDMNSVGYRDKPYVL QI
80 100 120
ANDNSNUEYLPILGAERSCASRLALGDDSPAKERVGGVQSLGTGALRIGADF-A
.::r*:::: ::::: * :::: o : - :: - : :e::::::
AAKN-LDE YLPIGG E S S RISGTALRIGASFQ
140 160 180
31YNGTNNKNTPVYVSSPIWENHAVFSAA,GFKDIRSYRYWDAEKRGIDIQGFLNDLENA
RFF----KFSRDVFLPKPIWGNHrPIFRlAG-MQIQGYRYYDPKT1CGFDFEAVEDISKI
200 220 240
k'nr.rLVVL lbH lk}1-)kT1rQIA4V"lSt'Kr LdrPkFDfY-GFrAG,L2RDAWAL
PEQSVLLLHACHNPVPPEWKEIATVVKK NFFE5GE
260 280
RYEVSEGFEF-FCAQSFSKNFGLYNERVCNLTWGKEPESILQVESQMEKIVRIrEWSNPP
RHFIEQGEQGIN CLCYGERVE LKILIRPMYSNPP
300 320 340
SELRARLEALKTPG¶KWNHIETDQIGM
NtR NINPDIRKGR] IGMRIaSLK SQHITDQIGM
360 380 400
cyt FSEI'GNPKQ'VEYLVNEKHIYLLPSGRINVSGLTTKNLDYVATSI AVrKIQ
mit FCF]'XGLKPEQVERLIKEFSIYMTKDGRISVAGVTSSNVGYIAHAE-VVrK
Fig. 3. Comparison of the amino acid sequences of human cytosolic and mitochondrial aspartate aminotransferases
The symbol: indicates identical residues, whereas the symbol . indicates conservative substitutions. The symbol - indicates gaps introduced to
maximize homology between the isoenzymes.
marized in Fig. 1. Not all the expected peptides were isolated
(e.g. peptide SA-3 from digestion of peptide CN-1), but no
attempt was made to isolate missing peptides if the region
concerned had been sequenced from other digests.
Some unusual cleavages were observed, i.e. at Gly- 115, Ser-
148 and Asp-154. On the other hand, cleavage occurred only
partially at Glu-203 and Glu-406 [resulting in peptides SA-l IA
(183-206) and SA-25B (377-417); not shown in Fig. 1].
Amino acid sequence of cytosolic aspartate aminotransferase
from human liver
The amino acid sequence of the enzyme is given in Fig. 1 and
was mainly based on the results described above. In a small
number of cases direct evidence was not obtained for the position
of a particular peptide (SA-1O) or to establish the junction of two
peptides (T-5/T-6, T-22/T-23, T-23/T-24, T-24/T-25, T-28/
T-29). In these cases recourse was had to considerations of hom-
ology with other cytosolic aspartate aminotransferases (Fig. 2),
which allowed the positions to be assigned unambiguously.
For example peptides T-23, T-24 and T-25 share eight out of
eight, eight out of nine and 11 out of 14 identical residues
respectively with the corresponding region of the cytoplasmic
isoenyzme from pig heart (Fig. 2). Given the clear amino acid
analyses and sequence data for these peptides (see Supplementary
Publication SUP 50158), this region of the structure may be
considered to be firmly established.
Peptide CN-2 gave a clear N-terminal sequence except for the
third residue, which could not be identified; the remainder of the
N-terminal sequence was consistent with those of peptides T-21
and T-22. The amino acid composition was poor, so that residue
3 could not be obtained by difference, and attempts to improve
these analyses were unsuccessful. Hence, although for reasons
given above the rest of the sequence covered by peptide CN-2 is
secure, residue 215 remains unidentified. It is given in Fig. I as
arginine, since this amino acid is found at position 215 in all
other cytosolic aspartate aminotransferases sequenced to date.
The evidence for one residue (Lys-258) was weak, depending
only on the amino acid composition of peptide T-22. However,
this is the active-site lysine residue present in all aspartate
aminotransferases. In addition, Teranishi and co-workers [24]
have sequenced the active-site peptide from the human heart
cytosolic isoenzyme and find lysine at this position. Their
sequence, covering residues 242-266, is completely in agreement
with that presented here. They also sequenced residues 1-20 and
411-412, again with results in agreement with those given in
Fig. 1.
All other residues were identified directly, in most cases from
two or more peptides. Tryptophan residues were determined by
automated gas-phase analysis of appropriate peptides. Amid-
ation states of aspartic acid/asparagine and glutamic acid/
glutamine residues were also directly assigned with the exception
of Glu-57 and Glu-182, which were assigned on the basis of
specificity of S. aureus V8 proteinase (glutamic acid occurs in
these positions in all other aspartate aminotransferases).
Comparison of the sequence with those of other cytosolic
aspartate aminotransferases
This is shown in Fig. 2. For the other sequences, only those
residues differing from that found in the human isoenzyme are
shown. The human isoenzyme contains unique residues at
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positions 46, 54, 186, 198, 250, 278, 282, 389 and 390. The lack
of cysteine at position 390 is of particular interest, as discussed
above.
Comparison of the sequences of the cytosolic and mitochondrial
isoenzymes
The computer program of Lipman & Pearson [19] was used to
obtain the best alignment of the sequences of the two isoenzymes
(Fig. 3); the sequence of the mitochondrial isoenzyme was taken
from ref. [8] with one correction (Asp-234). In this comparison
both identities and conservative substitutions are indicated.
Conservative substitutions were taken to be those occurring with
a relative frequency of 1.30 or greater as defined by McLachlan
[25]. This is a more stringent definition than that employed by
Lipman & Pearson [19], based on Dayhoff's PAM250 matrix
[26].
Gaps required for optimal alignment occur at the same
positions as for other cytosolic and mitochondrial isoenzyme
pairs [9]. It is debatable whether it is justified to insert a gap at
residues 250/251 in the cytosolic isoenzyme and 253/254 in the
mitochondrial form; these gaps allow for matching ofan adjacent
cysteine residue, but cysteine residues are not particularly highly
conserved in these isoenzymes.
Aligned as shown in Fig. 3, the isoenzymes have 48 % identical
residues. These are not uniformly distributed. The regions 1-31,
120-137 (including four deletions in the mitochondrial iso-
enzyme), 275-295 and 335-349 are particularly highly variable.
Quantitative comparisons of sequences of aspartate
aminotransferases
Pair-wise comparisons were done, using the program of
Lipman & Pearson [19], of the sequences of the vertebrate
aspartate aminotransferases known to date, that is the cytosolic
isoenzymes from human (this work), pig [3], horse [9], rat [11],
mouse [10] and chicken [4], and the mitochondrial isoenzymes
from human [8], pig [3], horse [9], rat [6], mouse [10] and chicken
[5]. In each case the percentage sequence difference between pairs
was calculated; when two sequences of different lengths were
compared the percentage difference was calculated on the basis
of the longer sequence with gaps counted as mismatches.
Also calculated were the average number of amino acid
substitutions per site (K.) as defined by Kimura [20]. This is
given by K. = -In (1 -Pd-0.2pd2), where pd is the fraction of
amino acid sequence differences. Calculated in this way K.
values provide estimates of the total number of substitutions per
site, including multiple substitutions at a single site.
The results are summarized in Table 3 in terms of the mean
K. values for a particular set of comparisons together with the
standard deviations and the number of comparisons.
The average K. value for mammalian mitochondrial iso-
enzymes (0.068+0.015) is essential unchanged from that
Table 3. Mean K.. values for pairs of aspartate aminotransferases from
various sources
The K. value gives an estimate of the average number of
substitutions per site between any pair of isoenzymes.
No. of pairs
Comparison Mean K. ± s.D. compared
Mammalian mitochondrial
Mammalian cytosolic
All cytosolic versus
all mitochondrial
0.068 + 0.015
0.092 +0.021
0.857 +0.033
10
10
36
(0.069 + 0.013) previously reported [9], as expected, since only
one new sequence (mouse) has been included. The value for
cytosolic isoenzymes differs considerably (0.092+0.021 com-
pared with 0.064). The value reported previously [9] was based
on a single comparison (pig/horse) and hence was considered
unreliable.
The essential point is that the two means are significantly
different at P < 0.01. Consequently the results presented here
constitute definitive evidence that the cytosolic aspartate amino-
transferase has evolved faster (by a factor of about 1.3) than the
mitochondrial isoenzyme in the mammalian lineage. This is
consistent with the observation of specific conservation of certain
residues ('m-residues') in the mitochondrial isoenzymes [5] and
with the possibility that extra structural constraints are imposed
on the structure of the mitochondrial isoenzyme concerned with
its uptake from its site of synthesis in the cytosol into mito-
chondria.
Previous claims [13] that mammalian cytosolic aspartate
aminotransferases have evolved faster than their mitochondrial
counterparts were based on immunochemical comparisons.
Although qualitatively correct, these conclusions were quan-
titatively grossly in error since the difference in rate of evolution
was estimated to be a factor of 2. This underlines the danger of
drawing conclusions about the degree of structural similarity
between proteins from anything other than direct sequence
determinations.
The absolute rates of evolution of the isoenzymes (k.) can
be calculated from k, = K,/2T, where T is the time elapsed
since divergence of mammals from their common ancestor [20].
Taking T = 80 x 106 years, then kaa = 0.43 x 10-9/year and
0.57 x 10-9/year for mammalian mitochondrial and cytosolic
isoenzymes respectively.
When all cytosolic and mitochondrial isoenzymes (including
those from chicken) are compared (Table 3), the average
K. value is 0.857 + 0.033. Assuming that the rates of evolution in
the two lines (cytosolic and mitochondrial) have not changed
and taking the mean number of substitutions/site per year
as 0.50 x 10-, then this puts the point of divergence of the
isoenzymes from their common ancestor at 860 x 106 years ago.
This value is somewhat different from that (109 years) previously
reported [9] because of the greater number of sequences now
available for comparison.
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